The neuromodulation devices market is expanding swiftly, propelled by the increasing global incidence of chronic conditions such as pain, epilepsy, and depression. This growth is further supported by ...
Abbott has reported a third quarter revenue that comes in $24 million below consensus, as the company has chosen to reaffirm its 2025 outlook. Worldwide, the company reached $11.4 billion in sales for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results